{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:11:36Z","timestamp":1772849496907,"version":"3.50.1"},"reference-count":22,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Autoimmundiagnostics GmbH"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2022,6,29]]},"abstract":"<jats:p>\n            <jats:named-content content-type=\"genus-species\">Mycobacterium tuberculosis<\/jats:named-content>\n            (\n            <jats:italic>Mtb<\/jats:italic>\n            ) drug-resistance detection is crucial for successful control of tuberculosis. Line-probe assays (LPA) are frequently used to detect resistance to rifampin, isoniazid, fluoroquinolones (FQs), and second-line injectables (SLIs).\n          <\/jats:p>","DOI":"10.1128\/spectrum.00259-22","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T13:03:25Z","timestamp":1654607005000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":7,"title":["Clinical Evaluation of a Line-Probe Assay for Tuberculosis Detection and Drug-Resistance Prediction in Namibia"],"prefix":"10.1128","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-4322","authenticated-orcid":true,"given":"G.","family":"G\u00fcnther","sequence":"first","affiliation":[{"name":"Department of Pulmonology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"},{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"},{"name":"Department of Medicine, Katutura State Hospital, Windhoek, Namibia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Saathoff","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany"},{"name":"German Centre for Infection Research (DZIF), Partner Site Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rachow","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany"},{"name":"German Centre for Infection Research (DZIF), Partner Site Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ekandjo","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Diergaardt","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Marais","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lange","sequence":"additional","affiliation":[{"name":"Research Center Borstel, Leibniz Lung Center, Borstel, Germany"},{"name":"Tuberculosis Unit, German Center for Infection Research (DZIF), Borstel, Germany"},{"name":"Respiratory Medicine &amp; International Health, University L\u00fcbeck, L\u00fcbeck, Germany"},{"name":"Baylor College of Medicine and Texas Children's Hospital, Global TB Program, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Nepolo","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"World Health Organization. 2021. Global tuberculosis report 2021. License: CC BY-NC-SA 3.0 IGO. World Health Organization Geneva Switzerland."},{"key":"e_1_3_3_3_2","unstructured":"World Health Organization. 2021. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis\u2013rapid diagnostics for tuberculosisdetection 2021 update. License: CC BY-NC-SA 3.0 IGO. World Health Organization Geneva Switzerland."},{"key":"e_1_3_3_4_2","unstructured":"Global Laboratory Initiative. 2018. Line probe assays for drug-resistant tuberculosis detection interpretation and reporting guide for laboratory staff and clinicians. https:\/\/stoptb.org\/wg\/gli\/assets\/documents\/LPA_test_web_ready.pdf. Accessed 20 February 2022."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01075-2016"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.05.026"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.15.0221"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02597-13"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.09.010"},{"key":"e_1_3_3_10_2","unstructured":"National Tuberculosis and Leprosy Programme. 2019. Namibia tuberculosis disease prevalance survey report. Ministry of Health and Social Services Windhoek Namibia. https:\/\/books.google.ch\/books\/about\/Namibia_tuberculosis_disease_prevalence.html?id=vhjVzgEACAAJ&redir_esc=y. Accessed 20 February 2022."},{"key":"e_1_3_3_11_2","unstructured":"Stop TB Partnership. 2021. TB Dasboard. http:\/\/www.stoptb.org\/resources\/cd\/NAM_Dashboard.html. Accessed 21 January 2022."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.18.0526"},{"key":"e_1_3_3_13_2","unstructured":"Ministry of Health and Social Services of Namibia. 2019. National guidelines for the management of tuberculosis fourth edition. https:\/\/www.namhivsociety.org\/media\/hivsoc\/Pdf\/National-Guidelines-for-the-Management-of-Tuberculosis-Fourth-Edition-2019.pdf. Accessed 22 February 2022."},{"key":"e_1_3_3_14_2","unstructured":"World Health Organization. 2014. High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting 28\u201329 April 2014 Geneva Switzerland. https:\/\/apps.who.int\/iris\/handle\/10665\/135617. Accessed 20 November 2022."},{"key":"e_1_3_3_15_2","first-page":"1295","article-title":"Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata","volume":"14","author":"Chamie G","year":"2010","unstructured":"Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, Okwera A, Whalen CC, Mugerwa RD, Havlir DV, Charlebois ED. 2010. Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int J Tuber Lung Dis 14:1295\u20131302.","journal-title":"Int J Tuber Lung Dis"},{"key":"e_1_3_3_16_2","unstructured":"World Health Organization. 2016. The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs (policy guidance). https:\/\/apps.who.int\/iris\/handle\/10665\/246131. Accessed 20 November 2022."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010705.pub3"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013694.pub2"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009593.pub5"},{"key":"e_1_3_3_20_2","unstructured":"World Health Organization. 2021. Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin rifabutin and rifapentine). License: CC BY-NC-SA 3.0 IGO. World Health Organization Geneva Switzerland."},{"key":"e_1_3_3_21_2","unstructured":"Ministry of Health and Social Services of Namibia. 2017. Circular nr. 1 diagnostic algorithm for tuberculosis 2017. https:\/\/www.namhivsociety.org\/media\/hivsoc\/Pdf\/Nurses%20Corner\/circular-01-2017-tb-diagnosticalgorithm.pdf. Accessed 20 February 22."},{"key":"e_1_3_3_22_2","first-page":"775","article-title":"Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria","volume":"87","author":"Kubica GP","year":"1963","unstructured":"Kubica GP, Dye WE, Cohn ML, Middlebrook G. 1963. Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis 87:775\u2013779.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.2144\/00291bm09"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00259-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00259-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:35:06Z","timestamp":1656509706000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00259-22"}},"subtitle":[],"editor":[{"given":"Rosemary C.","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6,29]]}},"alternative-id":["10.1128\/spectrum.00259-22"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00259-22","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"2022-04-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00259-22"}}